Allez Health’s $60 Million Capital Raise: A Monumental Breakthrough in Health Tech
Allez Health, a cutting-edge biosensor company specializing in continuous glucose monitoring (CGM), has secured $60 million in Series A+...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Authority FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Protocol Design Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Allez Health, a cutting-edge biosensor company specializing in continuous glucose monitoring (CGM), has secured $60 million in Series A+...
Gilead Sciences announced significant research findings to be presented at the European Association for the Study of the Liver...
The 2024 DIA Europe conference hosted a forward-thinking session titled “AI in Medicines Regulation: Beyond our Imagination.” The session...
The 2024 DIA Europe Conference brought together industry experts to explore the rapidly evolving medical device software and connected...
AngioDynamics, Inc. has obtained CE Mark approval in Europe for its AlphaVac F1885 System, enabling the non-surgical removal of...
Foundation Medicine has launched FoundationOne®RNA, an RNA sequencing test that complements its DNA-based FoundationOne®CDx. This combination provides enhanced fusion...
PathAI, a leader in AI-powered pathology, launches an Early Access Program (EAP) for its AISight Image Management System (IMS)...
CRIO, a leading eSource provider, has secured a substantial investment from The Riverside Company. This funding will accelerate the...
Drug-resistant Acinetobacter baumannii is a significant global health threat, and the World Health Organization (WHO) has classified it as...
Beaconcure Inc., a leader in AI-driven clinical data validation, and Phastar Inc., a biometrics CRO, have partnered to streamline...